Intelligent Bio Solutions (INBS) issued a letter to shareholders from Harry Simeonidis, President and CEO, reflecting on a year of growth in ...
INmune Bio (INMB) announced, following a Type C meeting with the U.S. Food and Drug Administration, FDA, its intent to submit a Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback